Display options
Share it on

J Diabetes Res. 2013;2013:608923. doi: 10.1155/2013/608923. Epub 2013 Feb 25.

Dose effect and mode of inheritance of diabetogenic gene on mouse chromosome 11.

Journal of diabetes research

Naru Babaya, Hironori Ueda, Shinsuke Noso, Yoshihisa Hiromine, Koji Nojima, Michiko Itoi-Babaya, Misato Kobayashi, Tomomi Fujisawa, Hiroshi Ikegami

Affiliations

  1. Department of Endocrinology, Metabolism and Diabetes, Kinki University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-sayama, Osaka 589-8511, Japan.

PMID: 23671880 PMCID: PMC3647551 DOI: 10.1155/2013/608923

Abstract

The quantitative trait locus (QTL) mapping in segregating crosses of NSY (Nagoya-Shibata-Yasuda) mice, an animal model of type 2 diabetes, with nondiabetic strain C3H/He mice has identified diabetogenic QTLs on multiple chromosomes. The QTL on chromosome 11 (Chr11) (Nidd1n) showing the largest effect on hyperglycemia was confirmed by our previous studies with homozygous consomic mice, C3H-11(NSY), in which the NSY-derived whole Chr11 was introgressed onto control C3H background genes. C3H-11(NSY) mice also showed a streptozotocin (STZ) sensitivity. In the present study, we constructed heterozygous C3H-11(NSY) mice and the phenotypes were analyzed in detail in comparison with those of homozygous C3H-11(NSY) and C3H mice. Heterozygous C3H-11(NSY) mice had significantly higher blood glucose levels and STZ sensitivity than those in C3H mice. Hyperglycemia and STZ sensitivity in heterozygous C3H-11(NSY) mice, however, were not as severe as in homozygous C3H-11(NSY) mice. The body weight and fat pad weight in heterozygous C3H-11(NSY) mice were similar to those in C3H and homozygous C3H-11(NSY) mice. These data indicated that the introgression of Chr11 of the diabetes-susceptible NSY strain onto diabetes-resistant C3H caused marked changes in the glucose tolerance and STZ susceptibility even in a heterozygous state, and suggested that the mode of inheritance of a gene or genes on Chr11 for hyperglycemia and STZ sensitivity is additive.

References

  1. Biochem Biophys Res Commun. 2005 Mar 4;328(1):158-64 - PubMed
  2. Diabetologia. 1995 May;38(5):503-8 - PubMed
  3. J Clin Invest. 2000 Aug;106(3):329-33 - PubMed
  4. Mamm Genome. 2006 Sep;17(9):927-40 - PubMed
  5. Nat Genet. 2009 Jan;41(1):77-81 - PubMed
  6. Diabetes Res Clin Pract. 2001 Aug;53(2):67-71 - PubMed
  7. Nat Genet. 2009 Jan;41(1):89-94 - PubMed
  8. Diabetologia. 2007 Aug;50(8):1641-8 - PubMed
  9. Diabetes. 1998 Aug;47(8):1287-95 - PubMed
  10. Endocr J. 2001 Apr;48(2):241-7 - PubMed
  11. Metabolism. 2000 May;49(5):651-6 - PubMed
  12. Diabetologia. 2005 Apr;48(4):675-86 - PubMed
  13. Diabetes. 1999 May;48(5):1183-91 - PubMed
  14. Diabetologia. 2009 Sep;52(9):1866-70 - PubMed
  15. Diabetologia. 2010 Jul;53(7):1362-71 - PubMed
  16. Diabetologia. 2000 Jul;43(7):932-8 - PubMed
  17. Diabetes. 1999 May;48(5):1168-74 - PubMed
  18. Nat Genet. 2009 Jan;41(1):82-8 - PubMed
  19. Trends Genet. 2008 Dec;24(12):613-21 - PubMed

Publication Types